As such, an individual with a low-penetrance PMS2 PV, but high PRS and/or positive FH ends up with an estimated CRC risk similar to a MSH6 PV carrier without FH and/or low PRS (Additional file 2: Fig. S9, Table S7). This evidence concerns the gene MSH6 and colorectal carcinoma.